Literature DB >> 27757683

Letter to the Editor concerning "Surgical treatment of sacral chordoma: survival and prognostic factors" by C. Ruosi et al. (Eur Spine J; 2015; 24(Suppl 7):S912-S917.

Ming-Xiang Zou1, Guo-Hua Lv1, Xiao-Bin Wang1, Jing Li2.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27757683     DOI： 10.1007/s00586-016-4819-3

Source DB:  PubMed          Journal:  Eur Spine J        ISSN： 0940-6719            Impact factor:   3.134


× No keyword cloud information.
  16 in total

1.  Evaluation of the quality of prognosis studies in systematic reviews.

Authors:  Jill A Hayden; Pierre Côté; Claire Bombardier
Journal:  Ann Intern Med       Date:  2006-03-21       Impact factor: 25.391

2.  Sacral Chordoma: Long-term Outcome of a Large Series of Patients Surgically Treated at Two Reference Centers.

Authors:  Stefano Radaelli; Silvia Stacchiotti; Pietro Ruggieri; Davide Donati; Paolo G Casali; Emanuela Palmerini; Paola Collini; Marco Gambarotti; Luca Porcu; Stefano Boriani; Alessandro Gronchi; Piero Picci
Journal:  Spine (Phila Pa 1976)       Date:  2016-06       Impact factor: 3.468

3.  Association between tumor size and immunohistochemical expression of Ki-67, p53 and BCL2 in a node-negative breast cancer population selected from a breast cancer screening program.

Authors:  Angel González-Sistal; Alicia Baltasar Sánchez; Ma Carmen Del Rio; José Ignacio Arias; Michel Herranz; Alvaro Ruibal
Journal:  Anticancer Res       Date:  2014-01       Impact factor: 2.480

4.  In chordoma, metastasis, recurrences, Ki-67 index, and a matrix-poor phenotype are associated with patients' shorter overall survival.

Authors:  Adrian von Witzleben; Lukas T Goerttler; Jochen Lennerz; Stephanie Weissinger; Marko Kornmann; Regine Mayer-Steinacker; Alexandra von Baer; Markus Schultheiss; Peter Möller; Thomas F E Barth
Journal:  Eur Spine J       Date:  2015-09-23       Impact factor: 3.134

Review 5.  A review of the surgical management of sacral chordoma.

Authors:  B Kayani; S A Hanna; M D Sewell; A Saifuddin; S Molloy; T W R Briggs
Journal:  Eur J Surg Oncol       Date:  2014-04-25       Impact factor: 4.424

6.  Prognostic Factors in the Operative Management of Sacral Chordomas.

Authors:  Babar Kayani; Mathew David Sewell; Kimberly-Anne Tan; Sammy A Hanna; Richard Williams; Robin Pollock; John Skinner; Timothy W R Briggs
Journal:  World Neurosurg       Date:  2015-06-23       Impact factor: 2.104

Review 7.  Prognostic factor studies in oncology: osteosarcoma as a clinical example.

Authors:  S M Bentzen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-02-01       Impact factor: 7.038

8.  Surgical treatment of sacral chordoma: survival and prognostic factors.

Authors:  C Ruosi; G Colella; S L Di Donato; F Granata; M G Di Salvatore; F Fazioli
Journal:  Eur Spine J       Date:  2015-10-12       Impact factor: 3.134

9.  Identification of miR-140-3p as a marker associated with poor prognosis in spinal chordoma.

Authors:  Ming-Xiang Zou; Wei Huang; Xiao-Bin Wang; Guo-Hua Lv; Jing Li; You-Wen Deng
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

10.  Human telomerase reverse transcriptase (hTERT) and Ki-67 are better predictors of survival than established clinical indicators in patients undergoing curative hepatic resection for colorectal metastases.

Authors:  David L Smith; Jean-Charles Soria; Luc Morat; Qinghua Yang; Laure Sabatier; Diane D Liu; Rabih A Nemr; Asif Rashid; Jean-Nicolas Vauthey
Journal:  Ann Surg Oncol       Date:  2004-01       Impact factor: 5.344
View more
  1 in total

Review 1.  The Michel Benoist and Robert Mulholland yearly European Spine Journal Review: a survey of the "surgical and research" articles in the European Spine Journal, 2017.

Authors:  Robert C Mulholland
Journal:  Eur Spine J       Date:  2018-01-08       Impact factor: 3.134
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.